Physician profile
Andrew C Bright
NPI 1760524250
$21,150.98
in general payments reported to CMS, 2019-2025
31 companies · $290 in 2025
The $290 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $531 · 2020: $379 · 2021: $2,191 · 2022: $505 · 2023: $17K · 2024: $387 · 2025: $290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $15K · Food and Beverage: $2,080 · Travel and Lodging: $964.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $14,500.00 |
| Food and Beverage | $2,080.41 |
| Travel and Lodging | $964.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $15,675.86 | 2023-2024 | Davinci Xi, Da Vinci Surgical System |
| Avita Medical Americas, LLC | $1,768.51 | 2019-2023 | Recell |
| Smith+Nephew, INC. | $529.91 | 2019-2024 | Collagenase Santyl, Oasis, Versajet |
| Integra Lifesciences Corporation | $479.56 | 2021-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Polynovo North America LLC | $443.96 | 2022-2025 | Novosorb Btm |
| Kerecis Limited | $434.32 | 2021-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Organogenesis INC. | $393.10 | 2023 | Puraply |
| Baxter Healthcare | $367.40 | 2019-2025 | Artiss, Recothrom, Tisseel |
| Depuy Synthes Sales INC. | $278.50 | 2021-2023 | Synthecel |
| Acell, INC. | $151.96 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $73.31 | 2020-2025 | Zerbaxa, Dificid |
| Vericel Corporation | $64.00 | 2024 | Nexobrid |
| Polarityte, INC. | $60.83 | 2019 | |
| Xeris Pharmaceuticals, INC. | $46.17 | 2022 | |
| Medela LLC | $38.26 | 2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $34.55 | 2019-2021 | |
| Medline Industries LP | $33.61 | 2019-2024 | Medline Industries, INC. |
| Convatec INC. | $28.54 | 2023 | |
| Kls-Martin L.P. | $26.25 | 2019 | |
| Janssen Pharmaceuticals, INC | $23.56 | 2019 | |
| Z-Medica, LLC | $22.00 | 2019 | |
| Bioventus LLC | $20.98 | 2022 | |
| Trevena, INC. | $20.76 | 2023 | Olinvyk |
| Mallinckrodt Hospital Products INC. | $19.48 | 2022 | |
| Kci USA, INC. | $19.11 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $18.47 | 2019 | |
| Acera Surgical, INC. | $18.10 | 2019 | |
| Polymedics Innovations INC. | $17.64 | 2025 | |
| Astellas Pharma US INC | $15.26 | 2019 | |
| Zimmer Biomet Holdings, INC. | $13.74 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $13.28 | 2023 | Andexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Bright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.